Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Antidepressant effects of NKH-477

March 26, 1997

Cysteine protease inhibitors described by Senju

March 26, 1997

Sumitomo reveals antipsychotic agents with reduced side effects

March 26, 1997

Dolasetron effective for nausea and vomiting associated with high-dose cisplatin

March 25, 1997

Zeneca granted exclusivity for new formulation of propofol

March 25, 1997

Myotrophin scheduled for review in May

March 25, 1997

Second approval for Zomig

March 25, 1997

Topamax cleared for marketing in Canada

March 25, 1997

AIT-082 enters trials in patients in Canada

March 25, 1997

Dainippon presents broad-spectrum antiemetic agent

March 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...